Skip to main content

$2.00 0.07 (3.36%)

High

$2.02

Low

$1.95

Trades

7

Turnover

$14,184

Volume

7,103
30 June 2023 at 3:19pm
Register to track CYC and receive email alerts.
Subject
CYC Ann: Becoming a substantial holder from MUFG

CYC Ann: Becoming a substantial holder from MS

CYC Ann: Ceasing to be a substantial holder from MUFG

CYC Ann: Ceasing to be a substantial holder from MS

CYC Ann: Becoming a substantial holder from MUFG

CYC Ann: Becoming a substantial holder from MS

CYC Ann: Notice of Annual General Meeting/Proxy Form

CYC Ann: Appendix 4G

CYC Ann: Annual Report to shareholders

CYC Ann: Change of Share Registry Details

CYC Ann: S&P DJI Announces March 2021 Quarterly Rebalance

CYC Ann: Confirmation of Technegas USFDA Timetable

CYC Ann: Change of Director's Interest Notice - DH

CYC Ann: Change of Director's Interest Notice - TM

CYC Ann: Date of Annual General Meeting

CYC Ann: CYC Results Summary

CYC Ann: Preliminary Final Report

CYC Ann: Dividend/Distribution - CYC

CYC Ann: Change of Director's Interest Notice DH

CYC Ann: Change of Director's Interest Notice TM

CYC Ann: Appendix 2A LTIP

CYC Ann: Appendix 2A SPP

CYC Ann: Appendix 3B - Amended

CYC Ann: Cyclopharm Announces Results of Share Purchase Plan Offer

CYC Ann: Change in substantial holding - Chemical Overseas

CYC Ann: Change in substantial holding - Barings

CYC Ann: Change in substantial holding

CYC Ann: Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020

CYC Ann: Change in substantial holding from CVC

CYC Ann: Change of substantial shareholding from AEF

CYC Ann: Share Purchase Plan Offer Booklet

CYC Ann: Appendix 2A - Placement

CYC Ann: Cleansing Notice - Share Purchase Plan

CYC Ann: Cleansing Notice - Placement

CYC Ann: Change in substantial holding

CYC Ann: Change in substantial shareholding from AEF

CYC Ann: Proposed issue of Securities - CYC

CYC Ann: Cyclopharm Capital Raising Presentation

CYC Ann: Cyclopharm Successfully Completes A$30 Million Placement

CYC Ann: SNMMI Requests USFDA to Expedite Approval For Technegas

CYC Ann: Trading Halt

CYC Ann: USFDA Approval Progress for Technegas and Business Update

CYC Ann: Bell Potter Healthcare Conference

CYC Ann: Change of Director's Interest Notice TM

Register to track CYC and receive email alerts.

Similar Companies

AT1
COH
CSX
EMV
IBX
IPD
MX1
RSH
SOM